AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Gilead Sciences Executives Make Significant Trades Amid Market Volatility.
ByAinvest
Monday, Dec 1, 2025 4:58 pm ET1min read
Gilead Sciences, Inc. [GILD] recently disclosed that Jeffrey Bluestone, a member of the company's board of directors, acquired 5,000 shares at a price of $64.92 per share on November 28, 2025, and subsequently sold an equivalent number of shares at $125.08 per share on the same day. Additionally, Kelly A. Kramer, another member of the board, purchased 2,806 shares at $81 per share on November 26, 2025, and then sold 2,805 shares at $127.10 per share on November 28, 2025, as well as 2,806 shares at $127.11 per share on the same day. Furthermore, Daniel Patrick O'Day, the company's director, chairman, and CEO, sold 3,212 shares at $125.91 per share on November 28, 2025, and an additional 6,788 shares at $126.84 per share on the same day. These transactions were reported in accordance with regulatory requirements.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet